GlaxoSmithKline says annual profits triple to £5.26 bln

February 7, 2012 in Other

British drugmaker GlaxoSmithKline said Tuesday that net profits more than tripled in 2011 compared with the previous year, as large efficiency savings offset falling revenues.

Earnings after tax surged to £5.261 billion (6.34 billion euros, $8.32 billion) in 2011, which compared with £1.634 in the previous year, GSK said in a results statement.

GSK added that it bounced back into the black in the fourth quarter, or three months to December, when net profit hit £1.25 billion. That compared with a net loss of £690 million a year earlier, when GSK took £2.17 billion in legal charges linked to its former diabetes drug Avandia.

The drug was pulled from European shelves in 2010 on fears that it increased the risk of heart attack and strokes.

GSK added Tuesday that revenues fell to £27.387 billion last year, reflecting lower sales of Avandia, anti-viral medicine Valtrex and pandemic flu vaccines.

Chief executive Andrew Witty cautioned about the fragile global economic outlook but predicted the group would increase shareholder returns this year as a result of ongoing efficiency measures.

"As we go into 2012, we are mindful of the potential pressures we face given the current global political and economic environment," Witty said in the release.

"However, we continue to expect to drive further shareholder returns as we seek to grow sales across our broadly based business and improve operational leverage and financial efficiency to deliver strong cash generation.

"We will also continue to invest appropriately in the business to generate sustainable and profitable sales growth," he added.

In early afternoon deals, GSK's share price fell 1.87 percent to 1,393 pence on London's FTSE 100 index of leading companies, which was 0.68 percent lower at 5,852.10 points.

Witty, who took the top job in 2008, has sought to diversify into consumer health care, emerging markets and biotechnology, as the pharmaceuticals industry faces competition from generic drugmakers.

(c) 2012 AFP

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Future doctors unaware of their obesity bias

Two out of five medical students have an unconscious bias against obese people, according to a new study by researchers at Wake Forest Baptist Medical Center. The study is published online ahead of print in the Journal of ...

Other created 40 minutes ago | popularity not rated yet | comments 0

Plastic realistic: Medical students to use plastinated human bodies for anatomy learning

Nanyang Technological University's (NTU) new medical school will be pioneering the use of plastinated bodies for medical education in Singapore.

Other created 9 hours ago | popularity not rated yet | comments 0

Survey points out deficiencies in addictions training for medical residents

A 2012 survey of internal medicine residents at Massachusetts General Hospital (MGH) – one of the nation's leading teaching hospitals – found that more than half rated the training they had received in addiction and other ...

Other created May 22, 2013 | popularity 5 / 5 (1) | comments 0

Early use of tracheostomy for mechanically ventilated patients not associated with improved survival

For critically ill patients receiving mechanical ventilation, early tracheostomy (within the first 4 days after admission) was not associated with an improvement in the risk of death within 30 days compared to patients who ...

Other created May 21, 2013 | popularity not rated yet | comments 0

Decisions to forgo life support may depend heavily on the ICU where patients are treated

The decision to limit life support in patients in the intensive care unit (ICU) appears to be significantly influenced by physician practices and/or the culture of the hospital, suggests new findings from researchers at the ...

Other created May 21, 2013 | popularity not rated yet | comments 0


Controlling mood through the motions of mitochondria

(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...

Statin use is linked to increased risk of developing diabetes, warn researchers

Treatment with high potency statins (especially atorvastatin and simvastatin) may increase the risk of developing diabetes, suggests a paper published today in BMJ.

Consumers largely underestimating calorie content of fast food

People eating at fast food restaurants largely underestimate the calorie content of meals, especially large ones, according to a paper published today in BMJ.

WHO: Scientific red tape mars efforts vs. virus

International efforts to combat a new pneumonia-like virus that has now killed 22 people are being slowed by unclear rules and competition for the potentially profitable rights to disease samples, the head ...

Dual-source cardiac CT IDs CAD in hard-to-image patients

(HealthDay)—In patients who have previously been considered difficult to image, dual-source cardiac (DSC) computed tomography (CT) can identify clinically significant coronary artery disease, according ...

Merck ends development of Parkinson's disease drug

(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.